[EN] Background: Platinum doublets are standard chemotherapy for advanced non-small-cell lung cancer (NSCLC). The aim of this study was to assess whether neutropenia is: (1) an indicator for treatment efficacy, or (2) ...
Urtasun, Andrea; Olivera, Gladys G.; Sendra, Luis; Aliño, Salvador F.; Berlanga, Pablo; Gargallo, Pablo; Hervás-Marín, David; Balaguer, Julia; Juan-Ribelles, Antonio; Andrés, María del Mar; Cañete, Adela; Herrero, María José(MDPI AG, 2023-03)
[EN] Simple Summary Cancer is still the leading cause of disease-related death in pediatric populations and an important source of morbidity. These can be due to the neoplasm itself but also to the treatment administered; ...
[EN] Background: In advanced-stage (IIIB or IV) non-small-cell lung cancer (NSCLC), combination chemotherapy has demonstrated response rates of 20% and a 1-year survival rate of 30%. We conducted a multicentre, open-label, ...